Heart Test Laboratories Stock Alpha and Beta Analysis
| HSCSW Stock | USD 0.10 0.00 0.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Heart Test Laboratories. It also helps investors analyze the systematic and unsystematic risks associated with investing in Heart Test over a specified time horizon. Remember, high Heart Test's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Heart Test's market risk premium analysis include:
Beta (9.60) | Alpha 5.39 | Risk 50.86 | Sharpe Ratio 0.19 | Expected Return 9.56 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Heart Test Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Heart Test market risk premium is the additional return an investor will receive from holding Heart Test long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Heart Test. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Heart Test's performance over market.| α | 5.39 | β | -9.61 |
Heart Test Fundamentals Vs Peers
Comparing Heart Test's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Heart Test's direct or indirect competition across all of the common fundamentals between Heart Test and the related equities. This way, we can detect undervalued stocks with similar characteristics as Heart Test or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Heart Test's fundamental indicators could also be used in its relative valuation, which is a method of valuing Heart Test by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Heart Test to competition |
| Fundamentals | Heart Test | Peer Average |
| Return On Equity | -2.2 | -0.31 |
| Return On Asset | -0.75 | -0.14 |
| Operating Margin | (857.13) % | (5.51) % |
| Revenue | 4.35 K | 9.43 B |
| Gross Profit | 5.02 K | 27.38 B |
| EBITDA | (8.14 M) | 3.9 B |
| Net Income | (8.77 M) | 570.98 M |
Heart Test Opportunities
Heart Test Return and Market Media
The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Acquisition by Andrew Simpson of 70000 shares of Heart Test at 0.001 subject to Rule 16b-3 | 11/25/2025 |
2 | Acquisition by Danielle Watson of 15000 shares of Heart Test subject to Rule 16b-3 | 12/22/2025 |
3 | Acquisition by Bent Bruce of 15000 shares of Heart Test subject to Rule 16b-3 | 01/12/2026 |
4 | Abbott stock price ticks higher as heart-device news lands ahead of earnings what investors watch - TechStock | 01/21/2026 |
5 | Acquisition by Wells David R. of 25000 shares of Heart Test at 4.37 subject to Rule 16b-3 | 01/30/2026 |
6 | New CareDx blood test spots post-transplant leukemia relapse earlier - Stock Titan | 02/03/2026 |
About Heart Test Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Heart or other stocks. Alpha measures the amount that position in Heart Test Laboratories has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 0.23 | 0.41 | 0.37 | 0.39 | Days Of Inventory On Hand | 2.3K | 1.8K | 2.1K | 2.0K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Heart Test in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Heart Test's short interest history, or implied volatility extrapolated from Heart Test options trading.
Build Portfolio with Heart Test
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.